{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:42:24Z","timestamp":1753886544057},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T00:00:00Z","timestamp":1460592000000},"content-version":"vor","delay-in-days":288,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ihj.2015.05.010","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T03:00:31Z","timestamp":1434337231000},"page":"311-317","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of anti-thrombotic strategies using Bivalirudin, Heparin plus Glycoprotein IIb\/IIIa inhibitors and Unfractionated Heparin Monotherapy for patients undergoing percutaneous coronary intervention \u2013 A single centre observational study"],"prefix":"10.1016","volume":"67","author":[{"given":"Upendra","family":"Kaul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Dua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind K.","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyadarshini","family":"Arambam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2015.05.010_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/IIIa blockade compared with Heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ihj.2015.05.010_bib2","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2015.05.010_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjcard.2012.03.051","article-title":"Meta-analysis comparing Bivalirudin versus Heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention","volume":"110","author":"Bertrand","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2015.05.010_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ahj.2013.11.013","article-title":"Impact of baseline hemorrhagic risk on the benefit of Bivalirudin versus unfractionated Heparin in patients treated with coronary angioplasty: a meta-regression analysis of randomized trials","volume":"167","author":"Tarantini","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2015.05.010_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjcard.2014.04.033","article-title":"Meta-analysis of randomized clinical trials comparing Bivalirudin versus heparin plus glycoprotein IIb\/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction","volume":"114","author":"Nairooz","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2015.05.010_bib6","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the society for cardiovascular angiography and interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2015.05.010_bib7","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2015.05.010_bib8","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(08)60623-6","article-title":"Treatment and outcomes of acute coronary syndromes in India (CREATE) : a prospective analysis of registry data","volume":"171","author":"Xavier","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2015.05.010_bib9","first-page":"106","volume":"002","author":"Braunwald","year":"1893","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2015.05.010_bib10","first-page":"2334","article-title":"Clinical end points in coronary stent trials, a case of standardised definition","volume":"115","author":"Donald","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2015.05.010_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jcin.2010.03.015","article-title":"Antithrombotic strategy in Non\u2013ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute coronary treatment and intervention outcomes Network) registry","volume":"3","author":"Lopes","year":"2010","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.ihj.2015.05.010_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehp437","article-title":"Safety and effectiveness of Bivalirudin in routine care of patients undergoing percutaneous coronary intervention","volume":"31","author":"Rassen","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2015.05.010_bib13","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ahj.2013.08.025","volume":"166","author":"Steg","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2015.05.010_bib14","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial","volume":"49","author":"Manoukian","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2015.05.010_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)60924-7","article-title":"Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial","author":"Shahzad","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2015.05.010_bib16","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2015.05.010_bib17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(09)61484-7","article-title":"Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial","volume":"374","author":"Mehran","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2015.05.010_bib18","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a glycoprotein IIb\/IIIa inhibitor versus Bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial","volume":"377","author":"Stone","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2015.05.010_bib19","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/jama.2015.2323","article-title":"Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial","volume":"313","author":"Han","year":"2015","journal-title":"JAMA"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483215001212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483215001212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T19:58:12Z","timestamp":1537559892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483215001212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0019483215001212"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2015.05.010","relation":{},"ISSN":["0019-4832"],"issn-type":[{"type":"print","value":"0019-4832"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of anti-thrombotic strategies using Bivalirudin, Heparin plus Glycoprotein IIb\/IIIa inhibitors and Unfractionated Heparin Monotherapy for patients undergoing percutaneous coronary intervention \u2013 A single centre observational study","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2015.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Cardiological Society of India. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}